Topic: trial safety


1. Roche

Roche is a big R&D spender, forking out CHF 11.53 billion ($11.42 billion) last year. Although at 22.8% of its total revenue, it’s not quite top in terms of percentages.

2. Biotrial and Bial

Both CRO Biotrial and Portuguese pharma partner Bial earn their place among the rotten tomatoes with patient fatalities, and investigations into their actions found problems that should not be overlooked.